Therapeutic cytokine stimulation of thrombocytopoiesis (Q33328414)

25 July 2017

1 reference

title

Therapeutic cytokine stimulation of thrombocytopoiesis (English)

1 reference

25 July 2017

Harker LA

1 reference

25 July 2017

publication date

1 June 1998

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

25 July 2017

1 reference

25 July 2017

page(s)

149-162

1 reference

A putative truncated cytokine receptor gene transduced by the myeloproliferative leukemia virus immortalizes hematopoietic progenitors

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

cMpl ligand is a humoral regulator of megakaryocytopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Purification and characterization of thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Stimulation of Platelet Production by Serum of Platelet-Depleted Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Kinetics of thrombopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Thrombocytopenia in c-mpl-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Thrombokinetics in man

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Serum thrombopoietin levels in patients with aplastic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Megakaryocyte growth and development factor (MGDF) moderately enhances in-vitro platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Identification of a functional receptor for granulocyte colony-stimulating factor on platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Platelet factors predisposing to arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

The bleeding time as a screening test for evaluation of platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Hemostatic Function, Survival, and Membrane Glycoprotein Changes in Young versus Old Rabbit Platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Epinephrine potentiates calcium mobilization and activation of protein kinases in platelets stimulated by ADP through a mechanism unrelated to phospholipase C

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Effect of recombinant human thrombopoietin in nonhuman primates with chemotherapy-induced thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Recombinant human ligand for MPL, megakaryocyte growth and development factor (MGDF), stimulates thrombopoiesis in vivo in normal and myelosuppressed baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

Thrombopoietin: the primary regulator of platelet production [see comments]

1 reference

https://api.crossref.org/works/10.1016%2FS0955-3886%2898%2900025-3

7 January 2021

10.1016/S0955-3886(98)00025-3

Identifiers

DOI

1 reference

25 July 2017

1 reference